|  |  |  |  |  |  |  | Random effects |  |
---|---|---|---|---|---|---|---|---|---|
Parameter | Â | Fixed effects | By Subject | ||||||
 | β | SE | 95% CI | t | p | δt |  | SD |  |
 | LL | UL |  |  | |||||
Intercept | .458 | .030 | .399 | .518 | 15.045 |  < .001*** |  |  | .122 |
 |  |  |  |  |  |  |  | Session |  |
Post-assessment | − .066 | .020 | − .105 | − .026 | − 3.286 |  < .01** | − 0.21 |  | .053 |
Follow up-assessment | − .069 | .027 | − .122 | − .015 | − 2.515 |  < .05* | − 0.22 |  | .078 |
Age | − .006 | .002 | − .011 | − .002 | − 2.672 |  < .05* | − 0.02 |  |  |
Medication status | − .072 | .030 | − .130 | − .014 | − 2.423 |  < .05* | − 0.23 |  |  |
Post-assessment*Age | .002 | .001 | − .000 | .004 | 1.700 | .11 | 0.01 |  |  |
Follow up-assessment*Age | .003 | .002 | .000 | .007 | 2.040 | .06 | 0.01 | Â | Â |
Post-assessment*Medication status | .042 | .029 | − .014 | .099 | 1.470 | .16 | 0.14 |  |  |
Follow up-assessment*Medication status | .053 | .039 | − .023 | .129 | 1.374 | .18 | 0.17 |  |  |